NCT05526092

Brief Summary

The overall objective of this research entity is to reveal the comprehensive health impact of oats in metabolically challenged individuals in a 6-week intervention, compared to that of rice. This is achieved by investigation of the lipids, short-chain fatty acids, inflammation markers and antioxidant status from plasma, fecal microbiome, and plasma metabolome. Additionally the effect of the 6-week diet on postprandial glycemia and postprandial satiety and vitality are investigated.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
20mo left

Started Sep 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress69%
Sep 2022Dec 2027

First Submitted

Initial submission to the registry

August 26, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 2, 2022

Completed
10 days until next milestone

Study Start

First participant enrolled

September 12, 2022

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
3.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Expected
Last Updated

April 13, 2026

Status Verified

March 1, 2026

Enrollment Period

1.3 years

First QC Date

August 26, 2022

Last Update Submit

April 7, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Changes from Baseline in Serum Total Cholesterol

    Serum total cholesterol will be measured from fasting blood samples at the baseline (week 0) and after 6 week of the dietary intervention (week 6).

    Week 0 and Week 6

  • Changes from Baseline in Interleukin-10

    Interleukin-10 is measured from fasting plasma samples at the baseline (week 0) and after the 6-week diet intervention (week 6). It will be analysed as part of the Olink Target 48 Cytokine Panel (Olink Proteomics, Uppsala, Sweden) that provides absolute quantities for 45 different proteins, such as interleukins, interferons, chemokines and growth factors that are related to inflammation.

    Week 0 and Week 6

Secondary Outcomes (19)

  • Changes from Baseline in Blood Lipids

    Week 0 and Week 6

  • Changes from Baseline in Glucose Metabolism

    Week 0 and Week 6

  • Changes in Postprandial Glucose metabolism

    0, 15, 30, 45, 60, 90, 120, 180 minutes after the study meal at week 0 and week 6

  • Changes from Baseline in Inflammation markers

    Week 0 and Week 6

  • Changes from Baseline in Plasma metabolome

    Week 0 and Week 6

  • +14 more secondary outcomes

Other Outcomes (7)

  • Changes in postprandial status of inflammation markers

    0, 15, 30, 45, 60, 90, 120, 180 minutes after the study meal at week 0 and week 6

  • Changes postprandial status of Plasma Short-Chain Fatty Acids

    0, 90, 180 minutes after the study meal at week 0 and week 6

  • Changes in postprandial status of Plasma metabolome

    0, 15, 30, 45, 60, 90, 120, 180 minutes after the study meal at week 0 and week 6

  • +4 more other outcomes

Study Arms (4)

Oat-rich and low-gluten diet with oat-rich meal test

EXPERIMENTAL

Participants will consume oats as the main cereal in their diet and follow low-gluten diet for 6 weeks. In postprandial meal test, they will be served an oat-rich breakfast.

Other: Dietary interventionOther: Postprandial meal test

Rice-rich low-gluten diet with oat-rich meal test

ACTIVE COMPARATOR

Participants will consume rice as the main cereal in their diet and follow low-gluten diet for 6 weeks. In postprandial meal test, they will be served an oat-rich breakfast.

Other: Dietary interventionOther: Postprandial meal test

Oat-rich low-gluten diet with rice-rich meal test

EXPERIMENTAL

Participants will consume oats as the main cereal in their diet and follow low-gluten diet for 6 weeks. In postprandial meal test, they will be served a rice-rich breakfast.

Other: Dietary interventionOther: Postprandial meal test

Rice-rich low-gluten diet with rice-rich meal test

ACTIVE COMPARATOR

Participants will consume rice as the main cereal in their diet and follow low-gluten diet for 6 weeks. In postprandial meal test, they will be served a rice-rich breakfast.

Other: Dietary interventionOther: Postprandial meal test

Interventions

Changes in dietary intake, metabolism, fecal microbiome, vitality and perceived health after a 6-week consumption of oat or rice-rich low-gluten diet.

Oat-rich and low-gluten diet with oat-rich meal testOat-rich low-gluten diet with rice-rich meal testRice-rich low-gluten diet with oat-rich meal testRice-rich low-gluten diet with rice-rich meal test

Postprandial changes after the 6-week consumption of either oat or rice-rich low-gluten diet, including blood markers, microbiome, satiety, recovery and vitality.

Oat-rich and low-gluten diet with oat-rich meal testOat-rich low-gluten diet with rice-rich meal testRice-rich low-gluten diet with oat-rich meal testRice-rich low-gluten diet with rice-rich meal test

Eligibility Criteria

Age30 Years - 68 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Commits to follow the instructed low-gluten diet for 6 weeks
  • years of age
  • BMI \> 25 kg/m\^2
  • High cholesterol (without medication) characterized as total cholesterol \> 5 mmol/l, AND either LDL \> 3 mmol/l OR HDL (men/women) \< 1.0/1.2 mmol/l AND/OR Hypertension (systolic \> 140 mmHg or diastolic \> 90 mmHg).

You may not qualify if:

  • Regular medication that can affect the research outcomes (balanced medication for hypertension, hypo-/hyperthyroidism, hormone replacement therapy, and inhaled medicines allowed)
  • Pregnancy or lactation
  • Heavy smoking
  • Recent course of antibiotics (less than 3 months prior to the study)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Food Sciences, Department of Life Technologies, University of Turku

Turku, Turku, 20500, Finland

Location

Institute of Public Health and Clinical Nutrition, University of Eastern Finland

Kuopio, 70211, Finland

Location

Related Publications (1)

  • Mannila E, Nuotio P, Kuosmanen A, De Storvik S, Karlund A, Jukkara A, Tauriainen MM, Narvainen J, Kolehmainen M, Linderborg KM. Comparison of Low-Gluten Diets Rich in Oats or Rice-A 6-Week Randomized Clinical Trial With Metabolically Challenged Volunteers. Mol Nutr Food Res. 2025 Jun;69(12):e70076. doi: 10.1002/mnfr.70076. Epub 2025 May 7.

Related Links

MeSH Terms

Conditions

HypercholesterolemiaHyperlipidemiasHypertensionOverweightObesity

Interventions

Diet Therapy

Condition Hierarchy (Ancestors)

DyslipidemiasLipid Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesVascular DiseasesCardiovascular DiseasesOvernutritionNutrition DisordersBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Nutrition TherapyTherapeutics

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 26, 2022

First Posted

September 2, 2022

Study Start

September 12, 2022

Primary Completion

December 31, 2023

Study Completion (Estimated)

December 1, 2027

Last Updated

April 13, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will share

Sensitive volunteer data may only be shared for collaborative research purposes with a separate agreement with the data owner. Metagenomic sequencing data can be found with identifier PRJEB104478 from ENA.

Shared Documents
STUDY PROTOCOL, ICF, ANALYTIC CODE
Time Frame
IPD will be available once the primary publications are published.
Access Criteria
Only for collaborative research purposes with a separate agreement with the data owner, the accessibility of data and documents can be decided together.

Locations